Virus News and Research

Latest Virus News and Research

SARS-CoV-2 prevalence in England “Higher than at any time from May 2020.”

The UK was badly hit by the COVID-19 pandemic, with the numbers of patients requiring hospitalization high during the first wave of the infection.

6 Oct 2020

Plasma ACE2 concentration associated with increased risk of major cardiovascular events

A team of scientists at the Population Health Research Institute, Hamilton Health Sciences, and McMaster University, Hamilton, in Ontario, Canada, revealed that increased plasma ACE2 levels in the blood could indicate a higher risk of major cardiovascular events. The study is published in the journal The Lancet.

6 Oct 2020

SARS-CoV-2 and anti-COVID-19 drugs activate Kaposi sarcoma-associated herpesvirus

A new study published on the preprint server bioRxiv* aimed to investigate the impacts of COVID-19 on people with various illnesses. Specifically, the researchers at the Rockefeller Cancer Institute, and the University of Arkansas for Medical Sciences wanted to see the effects of COVID-19 on patients with cancer and other infectious diseases.

6 Oct 2020

Antibiotic treatment is as good as appendectomy for a majority of adults with appendicitis

Seven of 10 adults with appendicitis can safely avoid surgical removal of their appendix (appendectomy) for at least several months by receiving a course of antibiotics, according to early results of a U.S. study that is the largest to compare use of these drugs alone versus an operation for appendicitis treatment.

6 Oct 2020

Study shows why antiretroviral therapy does not work in certain HIV patients

Increasingly, UPMC's chief of infectious diseases - a well-regarded expert in HIV/AIDS - is contacted by a perplexed physician describing a patient with HIV who insists they are adhering to the daily medication regimen meant to keep the virus in check, but testing says otherwise.

6 Oct 2020

Chronic illnesses promote active SARS-CoV-2 infection via suppressed mucosal immunity

A recent paper published in the preprint server medRxiv in September 2020 discusses the “clinically relevant variation in the expression of COVID-19-related genes”, which is associated with the host and environmental factors, as well as host genetic factors.

6 Oct 2020

Thiopurines could help stop viral replication in human coronaviruses

Researchers from the Department of Microbiology & Immunology, Dalhousie University, University of Calgary, and Department of Biochemistry and Molecular Biology, University of British Columbia, Canada, worked with human coronaviruses in cell cultures to look for drugs that might prevent accumulation and replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

6 Oct 2020

Cats and dogs are low risk for SARS-CoV-2 transmission to humans

Researchers from the College of Veterinary Medicine and Biomedical Sciences, Colorado State University studied the possible transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among domestic cats and dogs.

5 Oct 2020

Production of six monoclonal antibodies against SARS-CoV-2 spike protein

Youjia Guo et al. in a recent bioRxiv preprint paper demonstrate the robust performance of mouse anti-SARS-CoV-2 spike monoclonal antibodies in immunoassays, including western blotting, ELISA, immunofluorescence, and immunoprecipitation and also neutralizing activity in vitro against SARS-CoV-2 infection.

5 Oct 2020

Development of a coarse-grained model of SARS-CoV-2 virion

A team of scientists of the University of Chicago and the University of California San Diego has developed a coarse-grained (CG) model of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virion. The model can be used as a valuable resource to perform multiscale simulations of the SARS-CoV-2 virion. The study is currently available on the bioRxiv* preprint server.

5 Oct 2020

Eli Lilly's LY-CoV555 antibody shows potential as COVID-19 treatment

Researchers in the United States and Canada have discovered a monoclonal antibody that potently neutralizes severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.

5 Oct 2020

New findings could improve investigation of T cell response to COVID-19

Researchers in the United States have made an important discovery about the processing and presentation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral peptides that provides a better understanding of the immune response to coronavirus disease 2019 (COVID-19) and may help facilitate the design of improved vaccines.

5 Oct 2020

Less than 10% of US adults have SARS-CoV-2 antibodies

A new study by researchers at Stanford University and Ascend Clinical Laboratory and published in the journal The Lancet in September 2020 reports the prevalence of antibodies to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus in a dialysis patient population in the US.

5 Oct 2020

Severe COVID-19 in pregnancy increases risk for adverse maternal and neonatal outcomes

A new study published in the American Journal of Obstetrics and Gynecology in September 2020 reports the impact of severe COVID-19 on pregnancy, making an important contribution to the management of the condition in this subgroup of patients.

5 Oct 2020

Macrophage subgroups may play pivotal role in COVID-19 lethality

Many researchers are attempting to identify risk factors for severe or critical COVID-19. A recent paper in the journal Medical Hypotheses in September 2020 suggests that macrophage class activation is one of the factors that determine the clinical phenotype of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

5 Oct 2020

Study fails to establish independent risk factors for SARS-COV-2 infection in HIV patients

As the COVID-19 pandemic continues to spread worldwide, a new study published in the International Journal of Infectious Diseases in September 2020 reports that people with HIV infection are not at greater risk of COVID-19 compared to the general population.

5 Oct 2020

High-quality masks could prevent viral transmission and reduce COVID-19 deaths

Researchers from North Carolina State University and Georgia Institute of Technology studied the effectiveness of wearing high-quality masks and face coverings for the prevention of SARS-CoV-2 transmission. Their study titled, “High-Quality Masks Can Reduce Infections and Deaths in the US,” was released on the preprint server medRxiv.

5 Oct 2020

Individual and socioeconomic factors associated with COVID infection, hospitalization and death

The coronavirus disease (COVID-19) pandemic is actively spreading across nations, with millions of people affected. In the United States alone, more than 7.45 million people have been infected, and more than 210,000 have died.

5 Oct 2020

Most Australians favourable to a COVID-19 vaccination

Now, a new study published on the preprint server medRxiv* by scientists at the University of New South Wales aimed to determine the public perfections regarding a future COVID-19 vaccine in Australia. They wanted to know if Australians would get the vaccine if one becomes available.

5 Oct 2020

COVID-19 spread rebounds quickly after relaxation of social distancing measures

Across the U.S., the relaxation of statewide physical distancing measures that are designed to control the COVID-19 pandemic frequently resulted in an immediate reversal of public health gains against SARS-CoV-2, the virus that causes the disease, researchers from Massachusetts General Hospital (MGH) and colleagues reported.

5 Oct 2020

Virus News and Research

Latest Virus News and Research

SARS-CoV-2 prevalence in England “Higher than at any time from May 2020.”

Plasma ACE2 concentration associated with increased risk of major cardiovascular events

SARS-CoV-2 and anti-COVID-19 drugs activate Kaposi sarcoma-associated herpesvirus

Antibiotic treatment is as good as appendectomy for a majority of adults with appendicitis

Study shows why antiretroviral therapy does not work in certain HIV patients

Chronic illnesses promote active SARS-CoV-2 infection via suppressed mucosal immunity

Thiopurines could help stop viral replication in human coronaviruses

Cats and dogs are low risk for SARS-CoV-2 transmission to humans

Production of six monoclonal antibodies against SARS-CoV-2 spike protein

Development of a coarse-grained model of SARS-CoV-2 virion

Eli Lilly's LY-CoV555 antibody shows potential as COVID-19 treatment

New findings could improve investigation of T cell response to COVID-19

Less than 10% of US adults have SARS-CoV-2 antibodies

Severe COVID-19 in pregnancy increases risk for adverse maternal and neonatal outcomes

Macrophage subgroups may play pivotal role in COVID-19 lethality

Study fails to establish independent risk factors for SARS-COV-2 infection in HIV patients

High-quality masks could prevent viral transmission and reduce COVID-19 deaths

Individual and socioeconomic factors associated with COVID infection, hospitalization and death

Most Australians favourable to a COVID-19 vaccination

COVID-19 spread rebounds quickly after relaxation of social distancing measures

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Newsletters you may be interested in